LVADs supplement the pumping of blood by weak hearts. Surgeons implant this mechanical device as a treatment option for severe heart conditions such as acute or chronic deterioration of cardiac functions and heart failure.
The key factors driving the growth of the LVAD market are increasing diabetic population, rising healthcare expenditure, ageing population and technological developments.

The global LVAD market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on LVAD volume and value at global level, regional level and company level. From a global perspective, this report represents overall LVAD market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of LVAD in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their LVAD manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abiomed
Berlin Heart
HeartWare International
Jarvik Heart
St. Jude Medical
Cardiac Assist
Evaheart
ReliantHeart
Sun Medical Technology Research
Sunshine Heart

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BTT Therapy
BTD Therapy
Destination Therapy
BTR Therap

Segment by Application
Hospitals
Ambulatory Surgical Centers